Rep. Kim Ferguson

Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency; (accompanied by bill, Senate, No. 767) of Jason M. Lewis for legislation to define modest meals and refreshments in prescriber education settings; (accompanied by bill, Senate, No. 778) of Paul W. Mark for legislation to bring down the cost of prescription drugs; (accompanied by bill, Senate, No. 783) of Mark C. Montigny and Michael J. Barrett for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices; (accompanied by bill, Senate, No. 784) of Mark C. Montigny for legislation relative to coverage for chronic illness; (accompanied by bill, Senate, No. 797) of Jacob R. Oliveira for legislation to bring down the cost of prescription drugs; (accompanied by bill, House, No. 619) of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry; (accompanied by bill, House, No. 1201) of Kate Hogan relative to the pricing of prescription drugs; (accompanied by bill, House, No. 1205) of Bradley H. Jones, Jr., and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs; (accompanied by bill, House, No. 1206) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers; (accompanied by bill, House, No. 1215) of John J. Lawn, Jr., and others relative to pharmacy benefit managers; (accompanied by bill, House, No. 1246) of William M. Straus relative to drug prices paid by carriers; and (accompanied by bill, House, No. 1247) of Alyson M. Sullivan-Almeida, Michael J. Soter and David F. DeCoste relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth, reports the accompanying bill (Senate, No. 2492).

By Representative Soter of Bellingham, a petition (accompanied by bill, House, No. 2954) of Michael J. Soter and others relative to property taxes for 100% disabled veterans. Revenue.

Maddy summaryThis bill creates a special commission to examine the contracts between MassHealth, the state's health insurance program for low-income residents, and pharmaceutical benefit managers. The commission will evaluate whether MassHealth should switch from its current drug purchasing model to a pass-through model, which would allow pharmacies to negotiate prices directly with drug manufacturers. The ten-member panel includes state officials, legislative leaders, and representatives appointed by the governor to advocate for both pharmaceutical benefit managers and pharmacies. Within one year of the bill's passage, the commission must submit its findings and any proposed legislation to relevant state committees.

Maddy summaryThis bill requires Massachusetts' MassHealth program and large health insurers to annually publish lists of prescription drugs that have seen significant price increases, specifically those with costs rising by 50% over five years or 15% in the last year. The Attorney General will then select up to 15 of the most expensive drugs from these lists and mandate that manufacturers provide detailed documentation justifying the price hikes. Additionally, the bill establishes a regulatory framework with penalties for non-compliance and requires the Attorney General to report findings to the legislature each December.

Maddy summaryThis bill aims to improve infection control in Massachusetts nursing facilities by creating a grant program to train Infection Preventionists and adjusting financial incentives for these homes. It directs the Department of Public Health to use federal funds to support specialized training for staff responsible for preventing disease spread. Additionally, the legislation requires the state to pay nursing homes for hiring full-time Infection Preventionists and provides daily supplemental payments for each isolation or quarantine room a facility sets up to contain infectious diseases. These changes directly affect nursing home operators and their employees by mandating specific staffing roles and funding mechanisms designed to enhance safety protocols.

Maddy summaryThis bill aims to stabilize nursing facilities in Massachusetts by updating how the state calculates Medicaid payment rates. It requires the Department of Health and Human Services to adjust rates annually based on official inflation data and to use cost reports from the previous two years rather than older figures. The legislation also mandates that nursing labor costs be set at the statewide average plus 10% and provides a minimum 5% rate increase for facilities where Medicaid residents make up at least 75% of their population. Additionally, it ensures that capital rates for specific construction projects, such as converting larger rooms into smaller ones, are calculated using a fixed methodology from 2019.

Maddy summaryThis bill requires employers in Massachusetts to publicly display salary ranges for job postings on their websites or other recruitment materials. It directly affects businesses and organizations that hire employees within the state by mandating transparency regarding compensation. The key provision is that these salary ranges must be clearly visible to applicants before they apply, ensuring candidates know the pay scale associated with a position. This measure aims to provide clearer information to job seekers without changing how employers determine or negotiate individual salaries.